Replace The HumansAI agents & platforms, verified

Insilico Medicine

End-to-end AI drug discovery platform (target identification through generative chemistry) with 40+ pipeline programs; lead asset rentosertib for idiopathic pulmonary fibrosis has completed Phase IIa and is advancing toward Phase III.

Independenthigh confidenceVerified 2026-08-01

This is where the depth lives — everything below is evidence-graded

How the product is positioned

End-to-end AI drug discovery platform (target identification through generative chemistry) with 40+ pipeline programs; lead asset rentosertib for idiopathic pulmonary fibrosis has completed Phase IIa

Our summary of the vendor’s positioning — verbatim claim not yet recorded

What we found

Level 1 · assistive

Seeded at the rubric default. No independent evidence of end-to-end task completion has been reviewed yet, so the lowest grade applies until it is.

Any human checkpoint here is a product setting, not a regulatory requirement — confirm how it is configured for your deployment.

Graded 2026-08-01 · re-check 2026-11-01

Procurement detail

Deployment
saasvendor documentation
Compliance
GxP-aligned R&D processesreport dates not disclosed — request before signing
Integrations
Internal computational chemistry and biology pipelines claim unverified
Pricing
customRevenue from pharma partnerships/licensing deals; not consumer-priced.
Human checkpoint
Requiredproduct setting
Named customers
Eli Lilly (partner)from cited sources

Will they still be here?

Independent
Funding
$2.75B expanded partnership commitment from Eli Lilly (March 2026); $400M+ raised across rounds; ~$1.5B valuation
Founded
2014
HQ
Hong Kong / New York, USA

Sources

Logo retrieved 2026-08-01from the vendor’s own site · trademark of Insilico Medicine, Inc.

Where it’s weak

Like all AI drug discovery firms, ultimate proof of platform value depends on Phase III success rates that are not yet established at scale.

Corrections

Vendors may submit factual corrections free of charge. We correct facts and publish the change. We do not accept payment to change a grade. Submit a correction →